{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:42:16Z","timestamp":1789123336174,"version":"build-2803163510"},"reference-count":11,"publisher":"Informa UK Limited","issue":"11","license":[{"start":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T00:00:00Z","timestamp":1403654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2014,11,2]]},"DOI":"10.3109\/10428194.2014.927462","type":"journal-article","created":{"date-parts":[[2014,5,31]],"date-time":"2014-05-31T03:33:45Z","timestamp":1401507225000},"page":"2417-2418","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["When indolent follicular lymphoma is not indolent"],"prefix":"10.1080","volume":"55","author":[{"given":"Tiffany","family":"Tang","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, Weill Cornell Medical College","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Martin","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, Weill Cornell Medical College","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,6,25]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.510.510"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.885513"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12288"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041869"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-116749"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28243"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2013.83"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-124487"},{"issue":"1","key":"e_1_3_2_10_1","article-title":"The single-agent Bcl-2 inhibitor ABT-199 (GDC-0199) in patients with relapsed\/refractory (R\/R) non-Hodgkin lymphoma (NHL): responses observed in all mantle cell lymphoma (MCL) patients","volume":"122","author":"Davids MS","year":"2013","unstructured":"Davids MS, Seymour JF, Gerecitano JF, et al. The single-agent Bcl-2 inhibitor ABT-199 (GDC-0199) in patients with relapsed\/refractory (R\/R) non-Hodgkin lymphoma (NHL): responses observed in all mantle cell lymphoma (MCL) patients. Blood 2013;122(Suppl. 1): Abstract 1789.","journal-title":"Blood"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314583"},{"issue":"1","key":"e_1_3_2_12_1","article-title":"The Bruton's tyrosine kinase inhibitor ibrutinib (PCI-32765) is active and tolerated in relapsed follicular lymphoma","volume":"120","author":"Fowler NH","year":"2012","unstructured":"Fowler NH, Advani RH, Sharman JP, et al. The Bruton's tyrosine kinase inhibitor ibrutinib (PCI-32765) is active and tolerated in relapsed follicular lymphoma. Blood 2012;120(Suppl. 1): Abstract 156.","journal-title":"Blood"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428194.2014.927462","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.3109\/10428194.2014.927462","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428194.2014.927462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:00:13Z","timestamp":1789120813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/10428194.2014.927462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,25]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11,2]]}},"alternative-id":["10.3109\/10428194.2014.927462"],"URL":"https:\/\/doi.org\/10.3109\/10428194.2014.927462","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-06-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}